Has Erika Maestas, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,649 in general payments to Erika Maestas, MD across 6 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Erika Maestas, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Erika Maestas, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Erika Maestas, MD

Hematology & Oncology · Albuquerque, NMNPI 1396162442

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,220 of the $2,649 with a category attached, or 83.8%. AstraZeneca accounts for 87.9% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2023 at $2,492 and has fallen 95.3% since, to $116 in 2024. That places this record below the midpoint for hematology & oncology clinicians in NM, where the typical reported total is $2,649.

$2,649in general payments, 2019–2025

Across 6 payments — averaging $441.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$2K
Exelixis Inc.$279
AbbVie$41

$877,683in research payments, 2019–2025

Across 115 payments — averaging $7632.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Exelixis Inc.$331K
Seagen Inc.$227K
Merck$147K
GSK$110K
Pfizer$63K

What the payments were for

Consulting fees$2,22084%
Food & beverage$42916%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	3	$2,330
Exelixis Inc.	2	$279
AbbVie	1	$41

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Cabometyx$162

How this compares

$2,649 in reported general payments places this provider in the 50th percentile of 54 hematology & oncology providers in New Mexico.

See all hematology & oncology providers in New Mexico →

Medicare billing

Part B allowed, 2024

$32,867

Medicare patients

Services billed

375

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ondansetron Hcl	37	$680
Prochlorperazine Maleate	27	$536
Oxycodone Hcl	14	$178
Potassium Chloride	12	$102
Levothyroxine Sodium	12	$69
Tamsulosin Hcl	11	$31

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Albuquerque

Ursa Brown GlabermanAlbuquerque$219K
Neda Hashemi SadraeiAlbuquerque$96K
Muhammad TarakjiAlbuquerque$34K
Yara AbdouAlbuquerque$25K
George AtwehAlbuquerque$24K
Scott HerbertAlbuquerque$14K
Jose AvitiaAlbuquerque$11K
Zoneddy DayaoAlbuquerque$10K
Toufic TannousAlbuquerque$10K
Amy TarnowerAlbuquerque$5K

See the full list for New Mexico →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →